SecBot SecBot
SC 13G/A ·Filed Nov 12, 2026

BBIO

BridgeBio Pharma, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 15h ago SEC0000908834-26-000518
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a 13D filing, which would signal activist intent. The increase by a passive holder is routine, but the size (7.3%) gives Farallon significant influence if it chooses to engage.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$78.17
T+0 close · Nov 12, 2026 · via day close
Latest settled
+0.17%
T+1 · $78.30
Vs SPY
+0.53%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $78.17entry
  2. T+1 · 4d ago +0.17%α +0.53% · $78.30
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Farallon Capital Management filed an amended Schedule 13G disclosing a 7.3% passive stake in BridgeBio Pharma as of September 30, 2026, up from 5.1% reported by BlackRock in late October. The increase adds approximately 4.6 million shares, reflecting continued accumulation by a major institutional investor.

Key Financial Metrics

Stake
7.3%
Stake Value
$1.1B
Investor
Farallon Capital Management, L.L.C.
Investor Type
hedge fund

Key Facts

  • Farallon Capital Management now holds 14,247,000 shares of BridgeBio Pharma common stock, representing 7.3% of shares outstanding as of September 30, 2026.
  • This is an amendment to a prior Schedule 13G, indicating an increase from the previously disclosed stake.
  • The filing is passive (Rule 13d-1(b)), with no intent to influence control of the company.
  • Shares are held through eight Farallon investment partnerships.

Financial Impact

Stake increased to 7.3% from a prior level; at the $15.2B market cap, the stake is valued at approximately $1.11B.

ownership percentage

Risk Factors

  • Passive filing status could change if Farallon later engages with management or seeks board representation.
  • No indication of activist intent at this time.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (29 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000908834-26-000518
Document: 0000908834-26-000518-index.html0000908834-26-000518
Document: 0000908834-26-000518.txt0000908834-26-000518

Track record

38 reports on BBIO

Performance horizon

10 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +26.76% at T+60 after the May 11, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Viewing Entry $78.17 Now $77.36 −1.04% settles Dec 11
  2. Nov 9, 20267d ago Institutional Cluster Bullish 4/10 Entry $77.93 Now $77.36 −0.73% settles Dec 8
  3. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $77.93 Now $77.36 −0.73% settles Dec 8
  4. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  5. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $74.95 Now $77.36 +3.22% settles Nov 30
  6. Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $70.82 Now $77.36 +9.23% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $68.12 Now $77.36 +13.56% settles Nov 19
  8. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $63.30 to $78.67 Now $77.36 +22.21% ▲ +24.28% +27.89% vs SPY
  9. Oct 6, 20265w ago Press Release Bullish 7/10 Entry $66.96 to $74.03 Now $77.36 +15.53% ▲ +10.56% +13.73% vs SPY
  10. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $66.96 to $74.03 Now $77.36 +15.53% ▲ +10.56% +13.73% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (10h 18m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026